Randomisierte kontrollierte Studie
In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?
Cochrane Clinical Answers · 2013
DOI: 10.1002/cca.100 ↗At a glance
Randomisierte kontrollierte Studie in Cochrane Clinical Answers, 2013. Written by William Cayley Jr. 27 references.
Abstract (original language)
Intet abstract tilgængeligt.
Cite
APA
Jr, W. C. (2013). In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.100
Vancouver
Jr WC. In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?. Cochrane Clinical Answers. 2013. doi:10.1002/cca.100
BibTeX
@article{Jr2013,
author = {Jr, William Cayley},
title = {In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?},
journal = {Cochrane Clinical Answers},
year = {2013},
doi = {10.1002/cca.100}
}
EUVIMED